TW
GILD icon

Traveka Wealth’s Gilead Sciences GILD Stock Holding History

Traveka Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Sell
1,638
-2
-0.1% -$264 0.07% 186
2026
Q1 		$229K Buy
+1,640
New +$230K 0.09% 161

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Traveka Wealth's GILD Position: Q2 2026 in Review

Traveka Wealth reduced its Gilead Sciences (GILD) stake by 0.12% in Q2 2026, selling an estimated $264 and leaving 1,638 shares worth $207K. The position accounts for 0.07% of the portfolio, ranked #186.

Traveka Wealth first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $229K in Q1 2026. 1,113 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Traveka Wealth held 1,638 shares of Gilead Sciences worth $207K as of Q2 2026.
  • Traveka Wealth sold 2 Gilead Sciences shares in Q2 2026, an estimated $264.
  • Gilead Sciences made up 0.07% of Traveka Wealth's portfolio in Q2 2026, its #186 holding.
  • Traveka Wealth first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Traveka Wealth's Gilead Sciences position peaked at $229K in Q1 2026.
  • 1,113 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.